Invesco has launched its first fund investing in Chinese healthcare companies set to benefit from key growth trends such as preimmunization and reform.
The China Healthcare Equity Fund is said to “embrace the take-off” of China’s healthcare sector, according to Chin Ping Chia, head of China A investments, business strategy and development.
“The China healthcare sector has strong potential to expand due to robust growth in healthcare spending underpinned by a rise in wealth and an ageing population, making healthcare a hugely important sector for China’s society and economy,” he said.
Managed by senior fund manager Chris Liu in Hong Kong, the strategy focuses on healthcare mid-cap stocks, investing in businesses across five sub sectors including medical devices, drug manufacturing, medical services and vaccine producers.
A Ucits-compliant Sicav, the portfolio will typically consist of between 30-40 stocks, according to Invesco.
Although companies will mainly be listed on the Shanghai or Shenzhen stock exchanges and traded via Stock Connect, the fund may also invest in securities listed or traded on other international exchanges.
© 2021 funds global asia 
At times like these, HSBC Asset Management easily pivots towards emerging markets.
The spotlight on growth markets and the need to be nimble and dynamic is ever-sharper, given the difficulty in predicting monetary policy in the world’s major nations.
A comprehensive, cost-effective, and transparent currency overlay hedging solution is crucial to mitigate FX exposure risks in the complex landscapes of Japan and China's FX markets, explains Hans Jacob Feder, PhD, global head of FX services at MUFG Investor Services.
Ross Dilkes, fixed income portfolio manager at Wellington Management, examines the opportunities and risks for bond investors presented by the region’s decarbonisation agenda.
Shareholders in Japan no longer accept below-par corporate governance standards. Changes are taking place, but there are still areas for improvement, says Tetsuro Takase at SuMi Trust.
Robert St Clair, head of investment strategy at Fullerton Fund Management, explores the reasons investors should be paying attention to the rising demand for healthcare in China.
China's internet market presents one of the most compelling long-term growth potentials for investors today, given the catalysts supporting the sector from both macro and fundamental perspectives, explains Dr Xiaolin Chen, head of international, KraneShares.
